Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

[content-module:CompanyOverview|NYSE:HUM]

Health insurance giant Humana Inc. (NYSE: HUM) stock initially rose in reaction to its fourth quarter of 2024 earnings report despite posting losses.

The medical sector giant was one of the first carriers to sound the alarm of rising inpatient utilization costs, notably with its Medicare Advantage (MA) plan members in Q4 2023.